Implementation of an antimicrobial stewardship programme in three regional hospitals in the south-east of Liberia: lessons learned.
JAC Antimicrob Resist
; 4(3): dlac069, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-35769809
Background: Antimicrobial stewardship (AMS) programmes can improve the use of antimicrobial agents. However, there is limited experience in the implementation of such programmes in low- and middle-income countries (LMICs). Objectives: To assess the effect of AMS measures in south-east Liberia on the quality of antimicrobial use in three regional hospitals. Methods: A bundle of three measures (local treatment guideline, training and regular AMS ward rounds) was implemented and quality indicators of antimicrobial use (i.e. correct compounds, dosage and duration) were assessed in a case series before and after AMS ward rounds. Primary endpoints were (i) adherence to the local treatment guideline; (ii) completeness of the microbiological diagnostics (according to the treatment guideline); and (iii) clinical outcome. The secondary endpoint was reduction in ceftriaxone use. Results: The majority of patients had skin and soft tissue infections (nâ=â108) followed by surgical site infections (nâ=â72), pneumonia (nâ=â64), urinary tract infection (nâ=â48) and meningitis (nâ=â18). After the AMS ward rounds, adherence to the local guideline improved for the selection of antimicrobial agents (from 34.5% to 61.0%, Pâ<â0.0005), dosage (from 15.2% to 36.5%, Pâ<â0.0005) and duration (from 13.2% to 31.0%, Pâ<â0.0005). In total, 79.7% of patients (247/310) had samples sent for microbiological analysis. Overall, 92.3% of patients improved on Day 3 (286/310). The proportion of patients receiving ceftriaxone was significantly reduced after the AMS ward rounds from 51.3% to 14.2% (Pâ<â0.0005). Conclusions: AMS measures can improve the quality of antimicrobial use in LMICs. However, long-term engagement is necessary to make AMS programmes in LMICs sustainable.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Sysrev_observational_studies
Idioma:
En
Revista:
JAC Antimicrob Resist
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Alemanha